Brent Pfeiffenberger
President and CEO at Century Therapeutics Inc.
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Century Therapeutics Inc., 2 years.
Chief executive roles
Outstanding · grade A+
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 100
175.9% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 11, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −13,850 | $1.94 | $26,869 |
| Sep 4, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −463 | $2.11 | $977 |
| Aug 14, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −31,172 | $1.92 | $59,850 |
| Jun 11, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −13,849 | $2.24 | $31,022 |
| Jun 5, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −463 | $2.13 | $986 |
| May 19, 2026 | Corbus Pharmaceuticals Holdings Inc. | Grant or award | +7,500 | — | — |
| May 15, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −31,172 | $2.34 | $72,942 |
| Mar 11, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −55,397 | $2.73 | $151,234 |
| Mar 6, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −463 | $2.56 | $1,185 |
| Feb 13, 2026 | Century Therapeutics Inc. | Shares withheld for tax | −31,172 | $1.75 | $54,551 |
| Feb 2, 2026 | Century Therapeutics Inc. | Grant or award | +475,000 | — | — |
| Dec 12, 2025 | Century Therapeutics Inc. | Open-market purchase | +52,000 | $0.58 | $30,160 |
| Dec 10, 2025 | Century Therapeutics Inc. | Shares withheld for tax | −463 | $0.53 | $245 |
| Nov 19, 2025 | Century Therapeutics Inc. | Open-market purchase | +35,000 | $0.50 | $17,500 |
| Nov 17, 2025 | Century Therapeutics Inc. | Open-market sale | −32,456 | $0.45 | $14,605 |
Questions about Brent Pfeiffenberger
What boards is Brent Pfeiffenberger on?
Brent Pfeiffenberger sits on the boards of Butterfly Network Inc., Century Therapeutics Inc. and Corbus Pharmaceuticals Holdings Inc.
What company is Brent Pfeiffenberger the CEO of?
Brent Pfeiffenberger has been President and CEO of Century Therapeutics Inc. since December 2023 and Brent Pfeiffenberger is President and CEO of Butterfly Network Inc.
How long has Brent Pfeiffenberger served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.